Why Strong EBITDA Can Still Hide Deal Risk

Strong EBITDA and a polished CIM can create a false sense of certainty. In many processes, the headline numbers look clean right up to signing. The risk is that the most material issues are not visible in the teaser or the first pass through the data room.

That is why we do not treat a strong presentation as proof of quality. We treat it as a starting point. If the numbers matter, the work has to go deeper than the surface story.

Why the headline can mislead

Revenue recognition issues, weak controls, and customer concentration are not always obvious in the initial materials. They often sit below the level of the summary financials and only become clear once the buyer tests the assumptions behind the reported performance.

A business can show strong EBITDA and still carry risks that affect value, structure, and post-close performance. If those risks are not identified early, buyers may discover them only after signing, when leverage is highest and options are limited.

What we look at before price is set

Our process starts with quality of earnings, working capital, and assumption testing before price is set. That sequence matters. It shifts the conversation from optimism to clarity and helps buyers understand what is repeatable, what is adjusted, and what is exposed.

Quality of earnings tells us whether EBITDA is supported by the underlying business. Working capital shows whether the company can sustain operations without unexpected cash pressure. Assumption testing challenges the logic behind the forecast, the customer base, and the operational story presented in the CIM.

These are not academic exercises. They are the filters that separate a well-marketed deal from a well-understood one.

Why diligence discipline protects valuation

When diligence starts with the right questions, buyers are better positioned to protect valuation and avoid surprises. That does not mean every issue becomes a red flag. It means the buyer knows which risks are manageable, which require structure, and which should affect price.

For private equity associates, M&A directors, and business buyers, the discipline is the same: do not let a clean presentation outrun the underlying evidence. The strongest deals are rarely the ones with the smoothest narrative. They are the ones where the numbers stand up to scrutiny.

At Riskova, our work is built around that standard. We help buyers move beyond the headline EBITDA and into the details that determine whether the deal is actually as strong as it looks. Learn more at Riskova.

For buyers serious about diligence, the lesson is simple: strong EBITDA is not enough. The question is whether the earnings are real, repeatable, and supported by the controls and assumptions behind them. That is where true deal clarity begins. Explore our approach at our diligence advisory services.